Local and systemic control of Ewing's bone sarcoma family tumors of the ribs

Antonio Briccoli, Michele Rocca, Mariacristina Salone, Emanuela Palmerini, Alba Balladelli, Cristina Ferrari, Maria Di Fiore, Gaetano Bacci

Research output: Contribution to journalArticle

Abstract

Background: A retrospective analysis of the results and relapse pattern was evaluated in 34 patients with Ewing's family bone tumors (EFBT) treated at Rizzoli Institute with neoadjuvant chemotherapy between 1983 and 2003. Objectives: The aim of the study was to evaluate treatment strategy and compare our results with those obtained in other studies. Methods: Local treatment in these patients was radiotherapy alone in 4 cases, surgery alone in 13 and surgery followed by radiotherapy in 17. Results: Five-year event-free survival (EFS) was 44%, no different from that observed in another 558 patients with EFBT located in other sites treated in the same period with neoadjuvant chemotherapy protocols. Eighteen patients had a systemic relapse, followed by local relapse in two and one patient had a local relapse alone. EFS was significantly correlated to the time interval between onset symptoms and beginning of treatment and, in operated patients to histologic response to preoperative treatment. Conclusions: We conclude that EFBT of the ribs, when treated with neoadjuvant chemotherapy, have an outcome similar to that of patients with EFBT located in other sites.

Original languageEnglish
Pages (from-to)222-226
Number of pages5
JournalJournal of Surgical Oncology
Volume100
Issue number3
DOIs
Publication statusPublished - 2009

Fingerprint

Ewing's Sarcoma
Ribs
Bone and Bones
Neoplasms
Recurrence
Drug Therapy
Disease-Free Survival
Radiotherapy
Therapeutics

Keywords

  • Chemotherapy
  • Ewing sarcoma family tumors
  • Radiation therapy
  • Rib
  • Surgery

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Local and systemic control of Ewing's bone sarcoma family tumors of the ribs. / Briccoli, Antonio; Rocca, Michele; Salone, Mariacristina; Palmerini, Emanuela; Balladelli, Alba; Ferrari, Cristina; Di Fiore, Maria; Bacci, Gaetano.

In: Journal of Surgical Oncology, Vol. 100, No. 3, 2009, p. 222-226.

Research output: Contribution to journalArticle

Briccoli, A, Rocca, M, Salone, M, Palmerini, E, Balladelli, A, Ferrari, C, Di Fiore, M & Bacci, G 2009, 'Local and systemic control of Ewing's bone sarcoma family tumors of the ribs', Journal of Surgical Oncology, vol. 100, no. 3, pp. 222-226. https://doi.org/10.1002/jso.21337
Briccoli, Antonio ; Rocca, Michele ; Salone, Mariacristina ; Palmerini, Emanuela ; Balladelli, Alba ; Ferrari, Cristina ; Di Fiore, Maria ; Bacci, Gaetano. / Local and systemic control of Ewing's bone sarcoma family tumors of the ribs. In: Journal of Surgical Oncology. 2009 ; Vol. 100, No. 3. pp. 222-226.
@article{b02536c3b951422c90025911ffca292a,
title = "Local and systemic control of Ewing's bone sarcoma family tumors of the ribs",
abstract = "Background: A retrospective analysis of the results and relapse pattern was evaluated in 34 patients with Ewing's family bone tumors (EFBT) treated at Rizzoli Institute with neoadjuvant chemotherapy between 1983 and 2003. Objectives: The aim of the study was to evaluate treatment strategy and compare our results with those obtained in other studies. Methods: Local treatment in these patients was radiotherapy alone in 4 cases, surgery alone in 13 and surgery followed by radiotherapy in 17. Results: Five-year event-free survival (EFS) was 44{\%}, no different from that observed in another 558 patients with EFBT located in other sites treated in the same period with neoadjuvant chemotherapy protocols. Eighteen patients had a systemic relapse, followed by local relapse in two and one patient had a local relapse alone. EFS was significantly correlated to the time interval between onset symptoms and beginning of treatment and, in operated patients to histologic response to preoperative treatment. Conclusions: We conclude that EFBT of the ribs, when treated with neoadjuvant chemotherapy, have an outcome similar to that of patients with EFBT located in other sites.",
keywords = "Chemotherapy, Ewing sarcoma family tumors, Radiation therapy, Rib, Surgery",
author = "Antonio Briccoli and Michele Rocca and Mariacristina Salone and Emanuela Palmerini and Alba Balladelli and Cristina Ferrari and {Di Fiore}, Maria and Gaetano Bacci",
year = "2009",
doi = "10.1002/jso.21337",
language = "English",
volume = "100",
pages = "222--226",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Local and systemic control of Ewing's bone sarcoma family tumors of the ribs

AU - Briccoli, Antonio

AU - Rocca, Michele

AU - Salone, Mariacristina

AU - Palmerini, Emanuela

AU - Balladelli, Alba

AU - Ferrari, Cristina

AU - Di Fiore, Maria

AU - Bacci, Gaetano

PY - 2009

Y1 - 2009

N2 - Background: A retrospective analysis of the results and relapse pattern was evaluated in 34 patients with Ewing's family bone tumors (EFBT) treated at Rizzoli Institute with neoadjuvant chemotherapy between 1983 and 2003. Objectives: The aim of the study was to evaluate treatment strategy and compare our results with those obtained in other studies. Methods: Local treatment in these patients was radiotherapy alone in 4 cases, surgery alone in 13 and surgery followed by radiotherapy in 17. Results: Five-year event-free survival (EFS) was 44%, no different from that observed in another 558 patients with EFBT located in other sites treated in the same period with neoadjuvant chemotherapy protocols. Eighteen patients had a systemic relapse, followed by local relapse in two and one patient had a local relapse alone. EFS was significantly correlated to the time interval between onset symptoms and beginning of treatment and, in operated patients to histologic response to preoperative treatment. Conclusions: We conclude that EFBT of the ribs, when treated with neoadjuvant chemotherapy, have an outcome similar to that of patients with EFBT located in other sites.

AB - Background: A retrospective analysis of the results and relapse pattern was evaluated in 34 patients with Ewing's family bone tumors (EFBT) treated at Rizzoli Institute with neoadjuvant chemotherapy between 1983 and 2003. Objectives: The aim of the study was to evaluate treatment strategy and compare our results with those obtained in other studies. Methods: Local treatment in these patients was radiotherapy alone in 4 cases, surgery alone in 13 and surgery followed by radiotherapy in 17. Results: Five-year event-free survival (EFS) was 44%, no different from that observed in another 558 patients with EFBT located in other sites treated in the same period with neoadjuvant chemotherapy protocols. Eighteen patients had a systemic relapse, followed by local relapse in two and one patient had a local relapse alone. EFS was significantly correlated to the time interval between onset symptoms and beginning of treatment and, in operated patients to histologic response to preoperative treatment. Conclusions: We conclude that EFBT of the ribs, when treated with neoadjuvant chemotherapy, have an outcome similar to that of patients with EFBT located in other sites.

KW - Chemotherapy

KW - Ewing sarcoma family tumors

KW - Radiation therapy

KW - Rib

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=70249099591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249099591&partnerID=8YFLogxK

U2 - 10.1002/jso.21337

DO - 10.1002/jso.21337

M3 - Article

C2 - 19548266

AN - SCOPUS:70249099591

VL - 100

SP - 222

EP - 226

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -